Cannabis stocks were mostly lower Thursday, a day after the top law enforcement official in the U.S. offered muted support for a bill that would protect companies in states that have legalized weed.
Attorney General William Barr told a Senate committee that he would rather have the approach taken by a cannabis reform bill than the current state of affairs, as MarketWatch’s Victor Reklaitis reported.
Barr said the Strengthening the Tenth Amendment Through Entrusting States Act, or States Act, a bipartisan bill introduced last week, is currently being circulated in the Justice Department for comment and as soon as DOJ officials have gathered those, they can work with lawmakers.
“Personally, I would still favor one uniform federal rule against marijuana but, if there is not sufficient consensus to obtain that, then I think the way to go is to permit a more federal approach so states can make their own decisions within the framework of the federal law and so we’re not just ignoring the enforcement of federal law,” he said.
Statistics Canada said an analysis of crowdsourced price data from Canadian cannabis consumers found that legal prices have been higher since legalization last October than black market prices. The average price per gram of legally purchased cannabis stands at $9.99, compared with an average $6.37 from illegal sources.
“Prior to legalization, the average price for illegally purchased dried cannabis was $6.79 per gram,” said the agency. “The purchase price from legal sources was, on average, 56.8% higher than the purchase price from illegal sources, according to the crowdsourcing data.
See: Cannabis stocks mixed with KushCo the latest company to uncover accounting errors
From Marijuana Business Daily and Viridian Capital Advisors comes the news that last week was the busiest for mergers and acquisition activity among publicly traded companies with 11 deals closing.
Also: Unilever’s Schmidt’s Naturals to launch hemp-oil deodorants in September
Seven involved companies that touch the plant, while the remaining were in adjacent businesses and services. Another three deals by privately owned companies brought the weekly total to 14, marking the second-busiest of the year so far.
L.A.-based Vertical Companies closed a $58 million Series A funding round that will help it expand its footprint and brands. Vertical President Smoke Wallin told MarketWatch the money came from family offices and high net worth individuals, as institutional investors remain leery of the sector, because of the federal ban.
“We’re in it for the long game,” he told MarketWatch in an interview, in which he outlined plans to create winning brands, and launch hemp and CBD product lines as soon as the regulations are clearer.
Read also: They’re over 60, selling marijuana — and say it’s ‘pretty damn cool’
Green Thumb Industries Inc.’s fiscal fourth-quarter earnings showed a strong operating performance and guidance for the first quarter was upbeat, according to Benchmark analyst Mike Hickey, who rates the stock
Hickey raised this price target to $17 from $16, equal to 21% above its current trading level. The stock was down 5% in line with the broader sector.
Aleafia Health Inc.
said it has increased its investment in CannaPacific Pty. Ltd, an Australian medical cannabis company that is licensed to grow and research the substance. Aleafia invested another AU$540,000 ($385,500) in the company. CannaPacific has closed its acquisition of a 108,000 square feet greenhouse in the Byron Bay region of New South Wales. Aleafia shares were down 3.9%.
Elsewhere in the sector, Canopy Growth Corp.
was down 4.6%, Aurora Cannabis Inc.
was down 2.9% and Cronos Group Inc.
was down 4.6%.
was down 4/3%, OrganiGram Holdings Inc.
was down 3.0%, MedMen Enterprises Inc. was down 2.0% and Cresco Labs
was down 4.3%. Hexo Corp. was down 1.9% and Green Organic Dutchman Holdings Ltd. was down 5.2%.
Read: Tilray stock rises after the company shows it can sell recreational pot
Also: Cannabis stocks climb after Tilray’s earnings, as New Jersey moves closer to legal weed
The Horizons Marijuana Life Sciences ETF
was down 2.5%, and the ETFMG Alternative Harvest ETF
was down 2.3%.
The Dow Jones Industrial Average
was down 0.2% and the S&P 500 index
was down 0.1%.
See also: In California’s Weed Country, wildfires burn both cash and crops
Cannabis Watch: All of MarketWatch’s coverage of cannabis companies
Ciara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
总检察长威廉•巴尔( William Barr )告诉参议院一个委员会，他宁愿让大麻改革法案采取的方法，也不愿像市场观察( MarketWatch )的维克多•莱科莱蒂斯( Victor Reklaitis )报道的那样，让当前的事态发展下去。
参见： Cannabis 股票与 KushCo 混合，后者是发现会计差错的最新公司
来自《大麻商业日报》( Marijuana Business Daily )和 Viridian Capital Advisors 的消息传出后，上周是上市公司并购活动最繁忙的一周，有11宗交易完成。
总部位于洛杉矶的垂直公司（ VerticCompanies ）结束了一轮5800万美元的 A 轮融资，这将有助于其扩大足迹和品牌。垂直型总统沃林告诉市场观察，资金来自家庭办公室和高净值个人，因为机构投资者仍然对该行业持谨慎态度，因为联邦禁令。
他在接受《市场观察》( MarketWatch )采访时表示：“我们正处于长期竞争之中。”在采访中，他概述了创建成功品牌的计划，并在监管更加清晰的情况下尽快推出大麻和 CBD 产品系列。
对该公司股票进行评级的 Benchmark 分析师迈克·希基( Mike Hickey )说，绿拇指实业公司( Green Thumb Industries Inc .)第四财政季度的盈利显示出强劲的经营业绩，第一季度的业绩预期是乐观的
Aleafia Health Inc 。
表示已经增加了对 CannaPacific Pty 的投资。是一家澳大利亚医用大麻公司，该公司被授权种植和研究这种物质。Aleafa 还向该公司投资540000澳元（385500美元）。在新南威尔士州的拜伦湾地区， CannaPacific 已经完成了108,000平方英尺温室的收购。Aleafia 股价下跌3.9%。
在该行业的其他领域， Canopy Growth Corp 。
下降了4.6%，奥罗拉（Aurora） Cannabis Inc 。
下跌2.9%， Cronos Group Inc 。
Tilray Inc 。
下降了4/3%， OrganiGram 控股公司。
下跌3.0%， MedMen Enterprises Inc .下跌2.0%， Cresco Labs 下跌
下跌了4.3%。Hexo Corp .下跌1.9%， Green Organic Dutchman Holdings Ltd .下跌5.2%。
阅读： Tilray 股价上涨后，该公司显示，它可以出售休闲壶
此外，随着新泽西州接近法律规定的“野草”， Tilray 的收益之后，坎纳比斯的股价也在攀升
Horizons Marijuana Life Sciences ETF
下跌2.5%， ETFMG 另类收获 ETF 下跌
另见：在加州的 Weed Country ，野火燃烧现金和农作物
大麻观察： MarketWatch 对大麻公司的所有报道
Ciara Linnane 是 MarketWatch 的投资和企业新闻编辑。她在纽约。